GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » E10

Lushang Freda Pharmaceutical Co (SHSE:600223) E10 : ¥0.25 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lushang Freda Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.25 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Lushang Freda Pharmaceutical Co's average E10 Growth Rate was -3.80% per year. During the past 3 years, the average E10 Growth Rate was -1.30% per year. During the past 5 years, the average E10 Growth Rate was -1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lushang Freda Pharmaceutical Co was 47.70% per year. The lowest was -1.30% per year. And the median was 10.60% per year.

As of today (2024-05-30), Lushang Freda Pharmaceutical Co's current stock price is ¥7.87. Lushang Freda Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.25. Lushang Freda Pharmaceutical Co's Shiller PE Ratio of today is 31.48.

During the past 13 years, the highest Shiller PE Ratio of Lushang Freda Pharmaceutical Co was 303.00. The lowest was 9.21. And the median was 33.62.


Lushang Freda Pharmaceutical Co E10 Historical Data

The historical data trend for Lushang Freda Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lushang Freda Pharmaceutical Co E10 Chart

Lushang Freda Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.26 0.27 0.25 0.25

Lushang Freda Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.26 0.26 0.25 0.25

Competitive Comparison of Lushang Freda Pharmaceutical Co's E10

For the Real Estate - Development subindustry, Lushang Freda Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lushang Freda Pharmaceutical Co's Shiller PE Ratio Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Lushang Freda Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lushang Freda Pharmaceutical Co's Shiller PE Ratio falls into.



Lushang Freda Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lushang Freda Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.06/115.2271*115.2271
=0.060

Current CPI (Mar. 2024) = 115.2271.

Lushang Freda Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201406 0.020 98.200 0.023
201409 0.080 98.900 0.093
201412 0.090 99.000 0.105
201503 0.030 99.900 0.035
201506 0.010 99.500 0.012
201509 0.040 100.500 0.046
201512 0.030 100.600 0.034
201603 0.020 102.200 0.023
201606 0.015 101.400 0.017
201609 0.050 102.400 0.056
201612 0.010 102.600 0.011
201703 0.020 103.200 0.022
201706 0.020 103.100 0.022
201709 0.050 104.100 0.055
201712 0.040 104.500 0.044
201803 0.020 105.300 0.022
201806 0.050 104.900 0.055
201809 0.060 106.600 0.065
201812 0.030 106.500 0.032
201903 0.040 107.700 0.043
201906 0.060 107.700 0.064
201909 0.080 109.800 0.084
201912 0.160 111.200 0.166
202003 0.060 112.300 0.062
202006 0.180 110.400 0.188
202009 0.170 111.700 0.175
202012 0.220 111.500 0.227
202103 0.085 112.662 0.087
202106 0.215 111.769 0.222
202109 0.190 112.215 0.195
202112 -0.140 113.108 -0.143
202203 0.060 114.335 0.060
202206 0.120 114.558 0.121
202209 -0.040 115.339 -0.040
202212 -0.110 115.116 -0.110
202303 0.130 115.116 0.130
202306 0.060 114.558 0.060
202309 0.040 115.339 0.040
202312 0.070 114.781 0.070
202403 0.060 115.227 0.060

Add all the adjusted EPS together and divide 10 will get our e10.


Lushang Freda Pharmaceutical Co  (SHSE:600223) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lushang Freda Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.87/0.25
=31.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Lushang Freda Pharmaceutical Co was 303.00. The lowest was 9.21. And the median was 33.62.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lushang Freda Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Lushang Freda Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Lushang Freda Pharmaceutical Co (SHSE:600223) Business Description

Traded in Other Exchanges
N/A
Address
No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
Executives
Li Hang senior management
Yin Wei Directors, senior managers
Shao Zhao Wei senior management
Wang Zhong Wu senior management
Dong Hong Lin Director
Zhou Hong Bo senior management
Li Lu senior management
Liu Zeng Wei senior management
Zhang Quan Li senior management
Xu Tao senior management
Ju Hai Bo Director
Zhao Xi Liang Director
Pi Xi Cai Supervisors

Lushang Freda Pharmaceutical Co (SHSE:600223) Headlines

No Headlines